Amedisys, Inc. (AMED)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Amedisys, Inc. (AMED) with AI Score 50/100 (Hold). Amedisys, Inc. provides healthcare services across the United States, focusing on home health, hospice, personal care, and high acuity care. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Amedisys, Inc. (AMED) Healthcare & Pipeline Overview
Amedisys, Inc. is a healthcare provider specializing in home health, hospice, personal care, and high acuity services across 38 states and the District of Columbia. With a market capitalization of $3.32 billion and a P/E ratio of 22.16, Amedisys addresses the growing demand for in-home healthcare solutions.
Investment Thesis
Amedisys presents a compelling investment case based on its established market presence and diversified service offerings within the growing home healthcare sector. The company's focus on home health and hospice care aligns with the increasing demand for cost-effective and patient-centric healthcare solutions. With a market capitalization of $3.32 billion and a profit margin of 6.2%, Amedisys demonstrates financial stability. Growth catalysts include expanding its high acuity care services and leveraging its existing infrastructure to penetrate new geographic markets. Potential risks include regulatory changes and increased competition from other home healthcare providers. The company's beta of 0.90 suggests moderate volatility relative to the market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $3.32 billion indicates a strong market valuation.
- P/E ratio of 22.16 suggests a moderate valuation relative to earnings.
- Profit margin of 6.2% reflects profitability within the healthcare services sector.
- Gross margin of 52.3% demonstrates efficient cost management.
- Presence in 38 states and the District of Columbia provides a broad geographic footprint.
Competitors & Peers
Strengths
- Diversified service offerings across home health, hospice, personal care, and high acuity care.
- Extensive network of care centers and healthcare professionals.
- Established relationships with hospitals and healthcare systems.
- Strong brand reputation and market presence.
Weaknesses
- Exposure to regulatory changes and reimbursement pressures.
- Competition from other home healthcare providers.
- Dependence on government funding and reimbursement policies.
- Potential for staffing shortages and labor cost increases.
Catalysts
- Expansion of high acuity care services to meet the growing demand for hospital-at-home models.
- Geographic expansion into underserved markets.
- Strategic acquisitions to expand service offerings and market reach.
- Leveraging technology to improve operational efficiency and enhance patient care.
Risks
- Changes in government regulations and reimbursement policies.
- Increased competition from other home healthcare providers.
- Economic downturns and reduced healthcare spending.
- Cybersecurity threats and data breaches.
Growth Opportunities
- Growth opportunity 1: Expansion of High Acuity Care Services: Amedisys can capitalize on the increasing demand for hospital-at-home models by expanding its High Acuity Care segment. This involves delivering acute medical care in patients' homes, reducing the need for hospital stays and lowering healthcare costs. The market for hospital-at-home services is projected to reach billions of dollars in the coming years, presenting a significant growth opportunity for Amedisys. Timeline: Ongoing.
- Growth opportunity 2: Geographic Expansion: Amedisys can expand its presence in underserved markets by establishing new care centers and acquiring existing providers. This involves identifying regions with a high demand for home health, hospice, and personal care services and developing a strategic plan for market entry. Geographic expansion can drive revenue growth and increase Amedisys's market share. Timeline: Ongoing.
- Growth opportunity 3: Strategic Acquisitions: Amedisys can pursue strategic acquisitions to expand its service offerings and geographic reach. This involves identifying companies with complementary services or a strong presence in key markets and integrating them into Amedisys's operations. Strategic acquisitions can accelerate growth and enhance Amedisys's competitive position. Timeline: Ongoing.
- Growth opportunity 4: Technology Adoption: Amedisys can leverage technology to improve operational efficiency, enhance patient care, and reduce costs. This involves implementing telehealth solutions, remote monitoring devices, and data analytics tools to streamline workflows and improve patient outcomes. Technology adoption can drive innovation and create a competitive advantage for Amedisys. Timeline: Ongoing.
- Growth opportunity 5: Partnerships with Healthcare Systems: Amedisys can form partnerships with hospitals and healthcare systems to provide integrated care solutions. This involves collaborating with healthcare providers to deliver seamless transitions of care from hospitals to patients' homes, reducing hospital readmissions and improving patient satisfaction. Partnerships can drive referrals and increase Amedisys's patient volume. Timeline: Ongoing.
Opportunities
- Expansion of high acuity care services to meet the growing demand for hospital-at-home models.
- Geographic expansion into underserved markets.
- Strategic acquisitions to expand service offerings and market reach.
- Leveraging technology to improve operational efficiency and enhance patient care.
Threats
- Changes in government regulations and reimbursement policies.
- Increased competition from other home healthcare providers.
- Economic downturns and reduced healthcare spending.
- Cybersecurity threats and data breaches.
Competitive Advantages
- Established market presence and brand recognition.
- Extensive network of care centers and healthcare professionals.
- Diversified service offerings across home health, hospice, personal care, and high acuity care.
- Strong relationships with hospitals and healthcare systems.
About AMED
Amedisys, Inc., founded in 1982 and headquartered in Baton Rouge, Louisiana, provides a range of healthcare services across the United States. The company operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment focuses on delivering skilled nursing, rehabilitation therapy, and social services to patients recovering from surgery, managing chronic conditions, or facing terminal illnesses. This segment aims to reduce hospital readmissions and improve patient outcomes through in-home care. The Hospice segment offers comfort and support to individuals dealing with terminal illnesses such as cancer, heart disease, pulmonary disease, and Alzheimer's. The Personal Care segment provides assistance with daily living activities, enabling patients to maintain independence and quality of life. The High Acuity Care segment delivers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, Amedisys owned and operated 331 home health care centers, 175 hospice care centers, 14 personal-care centers, and 8 high acuity care centers across 38 states and the District of Columbia. Amedisys's comprehensive service offerings and extensive geographic reach position it as a significant player in the evolving healthcare landscape.
What They Do
- Provides home health services, including skilled nursing and rehabilitation therapy.
- Offers hospice care for patients with terminal illnesses.
- Delivers personal care services to assist with daily living activities.
- Provides high acuity care services, bringing hospital-level care to patients' homes.
- Operates a network of care centers across 38 states and the District of Columbia.
- Focuses on improving patient outcomes and reducing hospital readmissions.
Business Model
- Generates revenue through providing home health, hospice, personal care, and high acuity care services.
- Receives payments from Medicare, Medicaid, private insurance, and individual patients.
- Operates a network of care centers and employs healthcare professionals to deliver services.
- Focuses on managing costs and improving operational efficiency to maximize profitability.
Industry Context
Amedisys operates within the expanding medical care facilities industry, driven by an aging population and a growing preference for in-home healthcare services. The industry is characterized by increasing demand for home health, hospice, and personal care services. Key competitors include LHC Group (LHCG) and AccentCare, reflecting a fragmented market with opportunities for consolidation and expansion. The industry is subject to regulatory oversight and reimbursement policies, which impact revenue and profitability.
Key Customers
- Individuals recovering from surgery or managing chronic conditions.
- Patients with terminal illnesses requiring hospice care.
- Individuals needing assistance with daily living activities.
- Hospitals and healthcare systems seeking to reduce readmissions and improve patient outcomes.
AMED Financials
AMED Price Today & Live Chart
Amedisys, Inc. (AMED) stock price: Price data unavailable
AMED Latest News
-
Stocks That Hit 52-Week Lows On Thursday
benzinga · Mar 23, 2023
-
Stocks That Hit 52-Week Lows On Thursday
benzinga · Mar 16, 2023
-
Stocks That Hit 52-Week Lows On Tuesday
benzinga · Mar 14, 2023
-
Stocks That Hit 52-Week Lows On Friday
benzinga · Dec 16, 2022
AMED Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AMED.
Price Targets
Wall Street price target analysis for AMED.
AMED MoonshotScore
What does this score mean?
The MoonshotScore rates AMED's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Leadership: Richard M. Ashworth
CEO
Richard M. Ashworth serves as the CEO of Amedisys, Inc. His career spans various leadership roles within the healthcare industry. Ashworth brings extensive experience in healthcare management, strategic planning, and operational execution. Prior to joining Amedisys, he held executive positions at leading healthcare organizations, where he focused on driving growth, improving patient outcomes, and enhancing operational efficiency. His expertise in healthcare delivery and business development positions him to lead Amedisys in a dynamic and competitive market.
Track Record: Under Richard M. Ashworth's leadership, Amedisys has focused on expanding its high acuity care services and leveraging technology to improve patient care. He has overseen strategic initiatives to enhance operational efficiency and drive revenue growth. Key milestones include expanding the company's geographic footprint and strengthening its relationships with hospitals and healthcare systems.
What Investors Ask About Amedisys, Inc. (AMED) — Healthcare
What does Amedisys, Inc. do?
Amedisys, Inc. provides a comprehensive suite of healthcare services, including home health, hospice, personal care, and high acuity care, across 38 states and the District of Columbia. The company operates a network of care centers and employs healthcare professionals to deliver services to patients in their homes. Amedisys focuses on improving patient outcomes, reducing hospital readmissions, and providing cost-effective healthcare solutions. The company's business model involves generating revenue through payments from Medicare, Medicaid, private insurance, and individual patients.
What do analysts say about AMED stock?
Analyst coverage of Amedisys, Inc. (AMED) reflects a generally positive outlook, driven by the company's strong market position and growth opportunities in the home healthcare sector. Key valuation metrics include a P/E ratio of 22.16 and a market capitalization of $3.32 billion. Growth considerations include the company's ability to expand its high acuity care services, leverage technology to improve operational efficiency, and navigate regulatory changes. Analyst consensus suggests a moderate growth trajectory, with potential upside from strategic acquisitions and partnerships.
What are the main risks for AMED?
Amedisys faces several key risks, including regulatory changes, reimbursement pressures, increased competition, and cybersecurity threats. Changes in government regulations and reimbursement policies can impact revenue and profitability. Increased competition from other home healthcare providers can erode market share. Cybersecurity threats and data breaches can disrupt operations and damage the company's reputation. These risks require careful management and mitigation strategies to ensure the company's long-term success.
What are the key factors to evaluate for AMED?
Amedisys, Inc. (AMED) currently holds an AI score of 50/100, indicating moderate score. Key strength: Diversified service offerings across home health, hospice, personal care, and high acuity care. Primary risk to monitor: Changes in government regulations and reimbursement policies. This is not financial advice.
How frequently does AMED data refresh on this page?
AMED prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven AMED's recent stock price performance?
Recent price movement in Amedisys, Inc. (AMED) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified service offerings across home health, hospice, personal care, and high acuity care. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider AMED overvalued or undervalued right now?
Determining whether Amedisys, Inc. (AMED) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying AMED?
Before investing in Amedisys, Inc. (AMED), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- AI analysis is pending and may provide additional insights.